Fluorescence Probes for ALKBH2 Allow the Measurement of DNA Alkylation Repair and Drug Resistance Responses

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• The DNA repair enzyme ALKBH2 plays a role in cancer development and chemotherapy resistance.
• ALKBH2 is being investigated as a diagnostic marker and therapeutic target for various cancers.
• Currently, no direct methods exist to measure ALKBH2 repair activity in vitro or biological samples.

Purpose of the Study:

• To develop a direct and specific method for measuring ALKBH2 activity.
• To create a tool for monitoring cellular ALKBH2 regulation in response to chemotherapy.
• To establish a high-throughput assay for drug discovery targeting ALKBH2.

Main Methods:

• Design of a highly specific, fluorogenic probe utilizing an oligonucleotide scaffold.
• Application of the probe for in vitro and cell lysate ALKBH2 activity measurements.
• Utilizing a simple fluorescence assay to monitor ALKBH2 activity in response to temozolomide treatment.

Main Results:

• The fluorogenic probe accurately reports on ALKBH2 activity both in vitro and in cell lysates.
• The probe allows for the monitoring of cellular ALKBH2 regulation in response to temozolomide, a chemotherapy drug.
• This method provides a simpler alternative to indirect techniques like qPCR and western blots for observing ALKBH2 activity changes.

Conclusions:

• A novel fluorogenic oligonucleotide probe enables direct measurement of ALKBH2 activity.
• This assay facilitates the study of cellular ALKBH2 regulation and response to chemotherapy.
• The developed probe offers a viable high-throughput platform for ALKBH2-targeted drug discovery.